Dr Peter Williamson

Dr Peter Williamson
Lecturer



I have worked in NHS for 37 years- the last 10 in Victoria hospital, Kirkcaldy within clinical and laboratory haematology. I took up a post as lecturer in the School of Medicine in June 2018 and will be teaching on both the BSc and ScotGEM courses.

data source: symbiosis

Research Overview from research@st-andrews

Recent publications listed in research@st-andrews
25 (of 38 published available) for pjw21 (source: University of St Andrews PURE)
Please click title of any item for full details

Non-European doctors and change in UK policy Peter Trewby, Gareth Williams, Peter John Williamson, Edward Barnes, Peter Carr, Jennifer Crilley, Alwyn Foden, Stephen Mitchell, Jeremy Murphy
British Medical Journal 2006 vol.332 pp.913-4
Pohl-Pinkus constrictions of hair following chemotherapy for Hodgkin's disease Peter John Williamson, David de Berker
British Journal of Haematology 2005 vol.128 pp.582
Four pedigrees of the cation-leaky hereditary stomatocytosis class presenting with pseudohyperkalaemia. Novel profile of temperature dependence of Na+–K+ leak in a xerocytic form Gore D. M., Layton Mark, Sinha A. K., Peter John Williamson, Vaidya Bijay, Connolly V., Mannix P., Chetty M. C., Nicolaou Anna, Stewart G. W.
British Journal of Haematology 2004 vol.125 pp.521-527
A randomised study comparing an oral regimen with intravenous for consolidation in patients over 55 years with AML in first complete remission GH Jackson , PRA Taylor , R Kaczmarski , RJ Mohamed , D Culligan , J Cullis , T Littlewood , G Summerfield , Peter John Williamson, G Knyba , D Samson
British Journal of Haematology 2000 vol.108 
Establishing the incidence of myelodysplastic syndrome Peter John Williamson, A R Kruger, P J Reynolds, T J Hamblin, D G Oscier
British Journal of Haematology 1994 vol.87 pp.743-5
Multisystem adverse reaction to lamotrigine J E Schaub, Peter John Williamson, E W Barnes, P N Trewby
Lancet 1994 vol.344 pp.481
A phase-III study of recombinant interleukin 2 and 5-fluorouracil chemotherapy in patients with metastatic colorectal cancer T J Hamblin, S Sadullah, Peter John Williamson, J Stevenson, R Oskam, P Palmer, C R Franks
British Journal of Cancer 1993 vol.68 pp.1186-9
Establishing the incidence of myelodysplastic syndrome Peter John Williamson, D G Oscier, A R Kruger, P J Reynolds, T J Hamblin
British Journal of Haematology 1993 vol.84 pp.33
Reduction of acute haemorrhage with aprotinin S Valentine, Peter John Williamson, D Sutton
Anaesthesia 1993 vol.48 pp.405-6
Dyskeratosis congenita fibroblasts are abnormal and have unbalanced chromosomal rearrangements I Dokal, J Bungey, Peter John Williamson, D Oscier, J Hows, L Luzzatto
Blood 1992 vol.80 pp.3090-3096
Post splenectomy sepsis Peter John Williamson
Haematology Reviews and Communications  1992 vol.6 pp.173-182
Stem cell origin of the hematopoietic defect in dyskeratosis congenita JC Marsh, AJ Will, JM Hows, P Sartori, PJ Darbyshire, Peter John Williamson, DG Oscier, TM Dexter, NG Testa
Blood 1992 vol.79 pp.3138-3144
Thrombotic thrombocytopenic purpura mimicking acute small bowel Crohn's disease P J Winwood, J P Iredale, Peter John Williamson, M Lesna, C A Loehry
Gut 1992 vol.33 pp.857-9
Bone marrow aspiration and biopsy Peter John Williamson, A G Smith
The British Journal of Hospital Medicine 1991 vol.46 pp.328-30
Defective erythropoiesis in myelodysplastic syndromes. Peter John Williamson, DG Oscier, AJ Bell, TJ Hamblin
Journal of Clinical Pathology 1991 vol.44 pp.965
Dyskeratosis congenita fibroblasts are morphologically abnormal and have unbalanced chromosomal rearrangements  I Dokal, J Bungey , Peter John Williamson, DG Oscier , J Hows , L Luzzatto
British Journal of Haematology 1991 vol.77 pp.175
Erythropoietin Peter John Williamson
Transfusion Science 1991 vol.12 pp.15-23
Red cell aplasia in myelodysplastic syndrome. Peter John Williamson, D G Oscier, A J Bell, T J Hamblin
Journal of Clinical Pathology 1991 vol.44 
A phase-II trial of recombinant interleukin-2 and 5-FU chemotherapy in patients with metastatic colorectal carcinoma T J Hamblin, V Inzani, S Sadullah, F K Stevenson, Peter John Williamson, J van der Plas, P Palmer, C R Franks
Cancer Treatment Reviews 1989 vol.16 Suppl A pp.163-7
CFU-GM dose effect in circulating stem cell autografts A J Bell, Peter John Williamson, S Thorogood , DG Oscier , TJ Hamblin
British Journal of Haematology 1989 vol.71 pp.89p
Cerebral Hodgkin's disease and progressive multifocal leucoencephalopathy Peter John Williamson, N C Allan, M A McIntyre
Clinical and laboratory haematology 1989 vol.11 pp.281-5
Circulating stem cell autografts in high-risk myeloma A J Bell, Peter John Williamson, J North, E J Watts, J R Stephens
British Journal of Haematology 1989 vol.71 pp.162-3
Circulating stem cell autografts in myeloma Peter John Williamson, A J Bell, J North, E J Watts, RD Hyde , FK Stevenson , DG Oscier , TJ Hamblin
British Journal of Haematology 1989 vol.71 pp.171
Pyogenic abscesses in the myelodysplastic syndrome Peter John Williamson, D G Oscier, G J Mufti, T J Hamblin
British Medical Journal 1989 vol.299 pp.375-6
The natriuresis following oral administration of the calcium antagonists--nifedipine and nitrendipine M D Ene, Peter John Williamson, C J Roberts, G Waddell
British Journal of Clinical Pharmacology 1985 vol.19 pp.423-7